Interpharm Holdings (Interpharm Holdings) EBITDA Margin % : -18.34% (As of Dec. 2007)

Interpharm Holdings EBITDA Margin % Chart

Interpharm Holdings Annual Data
	Trend	Jun98	Jun99	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07
EBITDA Margin %		Get a 7-Day Free Trial					-	14.47	2.89	-5.10	-10.83

Interpharm Holdings Quarterly Data
	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07
EBITDA Margin %	Get a 7-Day Free Trial															-20.95	-8.44	-42.20	-29.47	-18.34

Competitive Comparison of Interpharm Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Interpharm Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's EBITDA Margin % falls into.

Interpharm Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Interpharm Holdings's EBITDA Margin % for the fiscal year that ended in Jun. 2007 is calculated as

Interpharm Holdings's EBITDA Margin % for the quarter that ended in Dec. 2007 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interpharm Holdings  (GREY:IPAH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Interpharm Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Interpharm Holdings (Interpharm Holdings) Business Description